Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT

Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT

Ning Song,1 Ming Zhao,1,2 Yuji Wang,1 Xi Hu,1 Jianhui Wu,1 Xueyun Jiang,1 Shan Li,1 Chunying Cui,1 Shiqi Peng1 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedi...

Full description

Bibliographic Details
Main Authors: Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:Drug Design, Development and Therapy
Subjects:
mitoxantrone
methotrexate
mesoporous silica nanoparticles
cancer therapy
nanomedicine
Online Access:https://www.dovepress.com/nanomedical-strategy-to-prolong-survival-period-heighten-cure-rate-and-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/nanomedical-strategy-to-prolong-survival-period-heighten-cure-rate-and-peer-reviewed-article-DDDT

Similar Items